Back to today’s briefing

Story perspectives

Trump's Drug Pricing Order Faces Backlash Over Cost Concerns

4/20/2025

50 8

Left

Trump's Drug Pricing Controversy

President Trump's latest executive order on drug pricing has sparked backlash, with critics warning it may raise costs instead of lowering them. By extending delay periods for small-molecule drugs, the order could stifle Medicare negotiations, favoring pharmaceutical companies and jeopardizing transparency and competition, ultimately threatening consumer access to affordable medications.

Right

Trump Advocates Drug Reform

President Trump is championing reforms to slash prescription drug prices by taking aim at pharmacy benefit managers (PBMs) and cutting through bureaucratic red tape. His administration seeks to boost transparency and competition within the drug supply chain. Mark Cuban backs this initiative, believing it could save consumers billions and pave the way for affordable medications.

1 of 2

Trump's Drug Pricing Controversy

President Trump's latest executive order on drug pricing has sparked backlash, with critics warning it may raise costs instead of lowering them. By extending delay periods for small-molecule drugs, the order could stifle Medicare negotiations, favoring pharmaceutical companies and jeopardizing transparency and competition, ultimately threatening consumer access to affordable medications.

1 / 2